HEADER IMMUNE SYSTEM 07-DEC-12 2M1W TITLE TICAM-2 TIR DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TIR DOMAIN-CONTAINING ADAPTER MOLECULE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 75-235; COMPND 5 SYNONYM: TICAM-2, PUTATIVE NF-KAPPA-B-ACTIVATING PROTEIN 502, TRIF- COMPND 6 RELATED ADAPTER MOLECULE, TOLL-LIKE RECEPTOR ADAPTOR PROTEIN 3, COMPND 7 TOLL/INTERLEUKIN-1 RECEPTOR DOMAIN-CONTAINING PROTEIN; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TICAM2, TIRAP3, TIRP, TRAM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PGEX6P-1, PG-TF2 KEYWDS TIR DOMAIN, TICAM-2, TRAM, INNATE IMMUNITY, INTERFERON, IMMUNE SYSTEM EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Y.ENOKIZONO,H.KUMETA,K.FUNAMI,M.HORIUCHI,J.SARMIENTO,K.YAMASHITA, AUTHOR 2 D.M.STANDLEY,M.MATSUMOTO,T.SEYA,F.INAGAKI REVDAT 1 15-JAN-14 2M1W 0 JRNL AUTH Y.ENOKIZONO,H.KUMETA,K.FUNAMI,M.HORIUCHI,J.SARMIENTO, JRNL AUTH 2 K.YAMASHITA,D.M.STANDLEY,M.MATSUMOTO,T.SEYA,F.INAGAKI JRNL TITL STRUCTURES AND INTERFACE MAPPING OF THE TIR JRNL TITL 2 DOMAIN-CONTAINING ADAPTOR MOLECULES INVOLVED IN INTERFERON JRNL TITL 3 SIGNALING. JRNL REF PROC.NATL.ACAD.SCI.USA V. 110 19908 2013 JRNL REFN ISSN 0027-8424 JRNL PMID 24255114 JRNL DOI 10.1073/PNAS.1222811110 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SPARKY 3.113, CYANA 2.1 REMARK 3 AUTHORS : GODDARD (SPARKY), GUNTERT, MUMENTHALER AND REMARK 3 WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2M1W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 22-OCT-13. REMARK 100 THE RCSB ID CODE IS RCSB103104. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5MM [U-99% 13C; U-99% 15N] REMARK 210 TICAM-2 TIR-1, 50MM HEPES-NAOH-2, REMARK 210 10MM DTT-3, 5% [U-100% 2H] REMARK 210 GLYCEROL-4, 0.02 MG/ML DSS-5, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 3D HNCO; 3D HNCA; 3D REMARK 210 HN(CO)CA; 3D HNCACB; 3D CBCA(CO) REMARK 210 NH; 3D HBHA(CO)NH; 3D HN(CA)HA; REMARK 210 3D H(CCO)NH; 3D C(CO)NH; 3D HCCH- REMARK 210 TOCSY; 3D 1H-15N-NOESY; 3D 1H-13C REMARK 210 NOESY ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR 6.1C, NMRPIPE REMARK 210 2007.068.09.07, SPARKY 3.113, REMARK 210 TALOS 2007.068.09.07, CYANA 2.1 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 71 -168.19 -74.96 REMARK 500 1 PHE A 78 34.63 -89.23 REMARK 500 1 LEU A 79 150.90 -39.99 REMARK 500 1 ASP A 102 -66.28 -171.06 REMARK 500 1 VAL A 129 30.80 -92.84 REMARK 500 1 LEU A 138 88.26 -62.27 REMARK 500 1 ASP A 146 -73.15 -70.19 REMARK 500 1 ARG A 163 64.97 60.37 REMARK 500 1 LYS A 166 178.79 -49.64 REMARK 500 1 ASN A 193 98.04 -63.76 REMARK 500 1 PHE A 210 67.58 -101.20 REMARK 500 1 ASN A 227 -71.05 -92.22 REMARK 500 1 ARG A 231 -83.27 -87.62 REMARK 500 1 GLN A 232 36.74 -141.36 REMARK 500 1 PHE A 233 33.88 -149.86 REMARK 500 2 LEU A 79 140.59 -39.52 REMARK 500 2 ASP A 102 -62.99 -178.66 REMARK 500 2 MET A 115 111.10 -38.55 REMARK 500 2 ASN A 124 101.79 -58.34 REMARK 500 2 VAL A 129 31.16 -92.48 REMARK 500 2 LEU A 138 96.72 -62.43 REMARK 500 2 GLN A 164 -177.98 -50.63 REMARK 500 2 HIS A 165 39.58 -93.26 REMARK 500 2 TYR A 167 44.27 -84.95 REMARK 500 2 ASN A 168 142.31 -170.51 REMARK 500 2 PHE A 210 61.71 -101.49 REMARK 500 2 ARG A 231 -89.61 -89.86 REMARK 500 2 PHE A 233 -176.36 -176.63 REMARK 500 3 LEU A 79 159.33 -40.35 REMARK 500 3 GLN A 101 46.77 -87.84 REMARK 500 3 ASP A 102 -60.39 -175.80 REMARK 500 3 ARG A 119 171.02 -47.28 REMARK 500 3 GLN A 120 -68.24 -101.08 REMARK 500 3 VAL A 129 30.44 -92.86 REMARK 500 3 LEU A 138 88.19 -62.26 REMARK 500 3 LEU A 139 99.19 -56.93 REMARK 500 3 ARG A 163 49.77 32.42 REMARK 500 3 GLN A 164 -173.74 -52.37 REMARK 500 3 PHE A 210 69.45 -102.53 REMARK 500 3 ARG A 231 -85.72 -90.98 REMARK 500 3 PHE A 233 37.68 -151.52 REMARK 500 4 PHE A 78 40.33 -96.22 REMARK 500 4 LEU A 79 133.82 -39.97 REMARK 500 4 GLN A 101 46.73 -86.41 REMARK 500 4 ASP A 102 -63.74 -166.68 REMARK 500 4 GLN A 123 -33.75 -38.93 REMARK 500 4 ASN A 124 98.16 -56.31 REMARK 500 4 LEU A 138 90.14 -62.65 REMARK 500 4 ASP A 146 -73.11 -75.69 REMARK 500 4 TYR A 154 77.36 -116.67 REMARK 500 REMARK 500 THIS ENTRY HAS 267 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18882 RELATED DB: BMRB REMARK 900 RELATED ID: 2M1X RELATED DB: PDB DBREF 2M1W A 75 235 UNP Q86XR7 TCAM2_HUMAN 75 235 SEQADV 2M1W GLY A 70 UNP Q86XR7 EXPRESSION TAG SEQADV 2M1W PRO A 71 UNP Q86XR7 EXPRESSION TAG SEQADV 2M1W LEU A 72 UNP Q86XR7 EXPRESSION TAG SEQADV 2M1W GLY A 73 UNP Q86XR7 EXPRESSION TAG SEQADV 2M1W SER A 74 UNP Q86XR7 EXPRESSION TAG SEQADV 2M1W HIS A 117 UNP Q86XR7 CYS 117 ENGINEERED MUTATION SEQRES 1 A 166 GLY PRO LEU GLY SER GLU GLU VAL PHE LEU LYS PHE VAL SEQRES 2 A 166 ILE LEU HIS ALA GLU ASP ASP THR ASP GLU ALA LEU ARG SEQRES 3 A 166 VAL GLN ASN LEU LEU GLN ASP ASP PHE GLY ILE LYS PRO SEQRES 4 A 166 GLY ILE ILE PHE ALA GLU MET PRO HIS GLY ARG GLN HIS SEQRES 5 A 166 LEU GLN ASN LEU ASP ASP ALA VAL ASN GLY SER ALA TRP SEQRES 6 A 166 THR ILE LEU LEU LEU THR GLU ASN PHE LEU ARG ASP THR SEQRES 7 A 166 TRP CYS ASN PHE GLN PHE TYR THR SER LEU MET ASN SER SEQRES 8 A 166 VAL ASN ARG GLN HIS LYS TYR ASN SER VAL ILE PRO MET SEQRES 9 A 166 ARG PRO LEU ASN ASN PRO LEU PRO ARG GLU ARG THR PRO SEQRES 10 A 166 PHE ALA LEU GLN THR ILE ASN ALA LEU GLU GLU GLU SER SEQRES 11 A 166 ARG GLY PHE PRO THR GLN VAL GLU ARG ILE PHE GLN GLU SEQRES 12 A 166 SER VAL TYR LYS THR GLN GLN THR ILE TRP LYS GLU THR SEQRES 13 A 166 ARG ASN MET VAL GLN ARG GLN PHE ILE ALA HELIX 1 1 ASP A 89 GLN A 101 1 13 HELIX 2 2 ASN A 124 VAL A 129 1 6 HELIX 3 3 THR A 140 TYR A 154 1 15 HELIX 4 4 TYR A 154 VAL A 161 1 8 HELIX 5 5 PRO A 181 THR A 185 5 5 HELIX 6 6 GLY A 201 PHE A 210 1 10 HELIX 7 7 GLN A 211 PHE A 233 1 23 SHEET 1 A 3 GLY A 109 ILE A 111 0 SHEET 2 A 3 PHE A 81 LEU A 84 1 N ILE A 83 O ILE A 110 SHEET 3 A 3 THR A 135 LEU A 137 1 O ILE A 136 N VAL A 82 CISPEP 1 LYS A 107 PRO A 108 1 -0.12 CISPEP 2 LYS A 107 PRO A 108 2 0.07 CISPEP 3 LYS A 107 PRO A 108 3 0.02 CISPEP 4 LYS A 107 PRO A 108 4 -0.05 CISPEP 5 LYS A 107 PRO A 108 5 -0.03 CISPEP 6 LYS A 107 PRO A 108 6 -0.11 CISPEP 7 LYS A 107 PRO A 108 7 0.03 CISPEP 8 LYS A 107 PRO A 108 8 -0.03 CISPEP 9 LYS A 107 PRO A 108 9 -0.06 CISPEP 10 LYS A 107 PRO A 108 10 0.05 CISPEP 11 LYS A 107 PRO A 108 11 -0.05 CISPEP 12 LYS A 107 PRO A 108 12 0.17 CISPEP 13 LYS A 107 PRO A 108 13 0.06 CISPEP 14 LYS A 107 PRO A 108 14 -0.05 CISPEP 15 LYS A 107 PRO A 108 15 -0.05 CISPEP 16 LYS A 107 PRO A 108 16 -0.07 CISPEP 17 LYS A 107 PRO A 108 17 0.09 CISPEP 18 LYS A 107 PRO A 108 18 -0.05 CISPEP 19 LYS A 107 PRO A 108 19 0.02 CISPEP 20 LYS A 107 PRO A 108 20 -0.05 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 152 0 0 7 3 0 0 6 0 0 0 13 END